Platelet Hyperreactivity Project
NCT00976196 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110
Last updated 2015-12-02
Summary
The PHP study aims to delineate gene products involved in high on-treatment platelet reactivity in aspirin-treated cardiovascular patients.
Conditions
- Platelet Reactivity
Sponsors & Collaborators
-
Pierre Fontana
lead OTHER
Principal Investigators
-
Pierre Fontana, MD, PhD · University of Geneva
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2010-01-31
- Completion
- 2010-01-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
NCT02226926 ·Status: COMPLETED ·Phase: PHASE1
-
Platelet Hyperreactivity to Aspirin and Stroke
NCT00766896 ·Status: COMPLETED ·Phase: PHASE4
-
ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
NCT01184300 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Antiplatelet Drug Resistances and Ischemic Events
NCT00501423 ·Status: COMPLETED
-
Prevention of Cardiovascular Events by Antiplatelet Agents After Acute Coronary Syndrome
NCT01952392 ·Status: COMPLETED
-
Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
NCT00799396 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting
NCT01276691 ·Status: COMPLETED ·Phase: PHASE4
-
Platelet Drug Trial in Coronary Disease Progression
NCT00000496 ·Status: COMPLETED ·Phase: PHASE3
-
Aspirin Impact on Platelet Reactivity in Acute Coronary Syndrome Patients on Novel P2Y12 Inhibitors Therapy
NCT02049762 ·Status: COMPLETED ·Phase: PHASE4
-
Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
NCT01586975 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome
NCT05577988 ·Status: RECRUITING ·Phase: PHASE3
-
Reversal of the Antiplatelet Effects of Ticagrelor in Combination With Aspirin, Using Normal Platelets
NCT03005704 ·Status: UNKNOWN ·Phase: NA
-
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371 ·Status: TERMINATED ·Phase: PHASE4
-
Aspirin Reload Before Percutaneous Coronary Intervention: Reperfusion Indexes Evaluation.
NCT01374698 ·Status: COMPLETED ·Phase: PHASE4
-
Women With Chest Pain and Normal Coronary Arteries Study
NCT00743197 ·Status: TERMINATED ·Phase: NA
-
Heat Shock Protein 47 in Thrombosis
NCT06731673 ·Status: RECRUITING
-
Platelet Reactivity With Fentanyl, Morphine, or no Narcotic
NCT05367336 ·Status: TERMINATED ·Phase: PHASE2
-
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
NCT03424408 ·Status: COMPLETED ·Phase: NA
-
AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
NCT01915407 ·Status: COMPLETED
-
Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease
NCT01820429 ·Status: COMPLETED
-
Aspirin and Thienopyridine Resistance in Peripheral Arterial Disease
NCT03174990 ·Status: COMPLETED
-
Platelet Function in Patients With an Acute Coronary Syndrome
NCT01992484 ·Status: UNKNOWN
-
Physiopathology of Rapid Aspirin Desensitization
NCT01118546 ·Status: COMPLETED
-
Impact of Dabigatran and Phenprocoumon on ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
NCT01339819 ·Status: COMPLETED ·Phase: PHASE4